EMA Authorised: Rotarix (human rotavirus, live attenuated) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

Rotarix, a live attenuated human rotavirus vaccine, has been authorised for use in the European Union to prevent rotavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Status: Authorised. Therapeutic area: Immunization;Rotavirus Infections. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 20/04/2026